04/26/2024
3:24 PM | Tarsus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/26/2024
3:25 PM | Tarsus Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
7:34 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
1:56 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
1:06 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
6:03 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:04 PM | Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/19/2024
6:05 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:05 PM | Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:08 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
2:44 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
2:44 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
2:47 PM | Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:57 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:45 PM | Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:10 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:11 PM | Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:12 PM | Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:12 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:26 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
4:17 PM | Tarsus Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024
4:08 PM | Tarsus Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024
3:32 PM | Tarsus Pharmaceuticals (Filer)
| Form S-3ASR | |
02/27/2024
3:22 PM | Tarsus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2024
8:18 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:28 AM | RTW INVESTMENTS, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
9:06 AM | MORGAN STANLEY (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G | |
02/02/2024
11:40 AM | Cowen Financial Products LLC (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024
5:05 AM | Tarsus Pharmaceuticals (Subject)
TimesSquare Capital Management, LLC (Filed by)
| Form SC 13G/A | |
01/22/2024
4:05 PM | Paradigm Biocapital Advisors LP (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G | |
01/18/2024
3:30 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
8:00 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:08 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:23 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
4:30 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:32 PM | Tarsus Pharmaceuticals (Issuer)
Trevejo Jose M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:49 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
2:17 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023
5:30 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
8:01 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
5:27 PM | Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Long-Awaited End of America Update (Ad) A 995% Gain Last Time We Shared this "Election Secret"
It's a straightforward way to come out on top no matter who wins this November… It's not cryptos, or options, and anyone can do it. Click here to find out for free. |
12/01/2023
3:55 PM | Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:58 PM | Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
3:35 PM | Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
11:15 PM | Tarsus Pharmaceuticals (Filer)
| Form EFFECT | |
11/17/2023
3:50 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
3:53 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
3:00 PM | Tarsus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/20/2023
3:41 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
3:26 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/06/2023
4:21 PM | Tarsus Pharmaceuticals (Issuer)
Trevejo Jose M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
10:48 AM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023
4:30 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:30 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023
3:25 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
4:12 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
3:39 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023
5:02 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2023
7:47 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2023
4:42 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
4:46 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
3:34 PM | Greenstein Leonard M. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2023
3:54 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2023
3:38 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/14/2023
3:40 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:48 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2023
3:23 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
4:56 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
4:58 PM | CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:10 PM | Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
4:42 PM | Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
4:45 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
4:47 PM | LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
4:49 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:29 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
5:25 PM | CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
5:27 PM | Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
5:08 PM | LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
5:14 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
5:18 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
5:21 PM | Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:37 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:48 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:17 PM | Greenstein Leonard M. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023
3:52 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023
4:40 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
6:16 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:56 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023
4:40 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
6:49 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2023
4:21 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Have You Seen Elon’s New A.I. Device? (Picture Inside) (Ad) A strange new era for mankind is upon us...
And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day.
Elon believes A.I. is advancing so fast... This strange new device to protect us against that A.I. threat... |
05/19/2023
6:08 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
5:02 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144/A | |
05/17/2023
3:34 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2023
4:17 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2023
2:28 PM | Cowen Financial Products LLC (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G | |
05/02/2023
6:06 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
